AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ADVANCED MEDICAL SOLUTIONS GROUP PLC

Share Issue/Capital Change Sep 9, 2025

7467_rns_2025-09-09_315c442c-d5d3-4829-b125-a999dd6ac3e2.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6753Y

Advanced Medical Solutions Grp PLC

09 September 2025

9 September 2025

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies , makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

Name of applicant: Advanced Medical Solutions Group plc
Name of scheme: Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme
Period of return: From: 6 March 2025 To: 5 September 2025
Balance of unallotted securities under scheme(s) from previous return: 1. 1,739

2. Nil

3. 129,543

4. 167,103

5. 13,886

6. 245,821
Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil
Less:   Number of securities issued/allotted under scheme(s) during period: 1. 1,739

2. Nil

3. 41,970

4. 82,562

5. 13,886

6. 16,059
Equals:   Balance under scheme(s) not yet issued/allotted at end of period: 1. Nil

2. Nil

3. 87,573

4. 84,541

5. Nil

6. 229,762
Number and class of securities originally listed and the date of admission: 4,476,264 ordinary shares of 5p each on 6 September 2018.
Name of contact: Owen Bromley
Telephone number of contact: 01606 545514

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations
Optimum Strategic Communications Tel: +44 (0) 20 4566 8543
Mary Clark / Nick Bastin / Isabelle Abdou [email protected]
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597 5970
Gary Clarence / David Anderson
Berenberg (Joint Broker) Tel: +44 (0) 20 3207 7800
Toby Flaux / Detlir Elezi / Yasmina Benchekroun

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRUPUQPBUPAGMB

Talk to a Data Expert

Have a question? We'll get back to you promptly.